Showing results (221-230 of 518) with videos related to
Sort By:
Pageof 52
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchangeHesham Abboud, Alex Petrak, Maureen Mealy, et al.Journal of Visualized Experiments : Jove|June 13, 2015
Minimally-invasive Technique for Injection into Rat Optic NerveKateryna Raykova, Melina V Jones, Hwa Huang, et al.Journal of the Neurological Sciences|December 19, 2017
Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis opticaMayank R Ajmera, Audra Boscoe, Josephine Mauskopf, et al.IEEE Open Journal of Engineering in Medicine and Biology|April 11, 2022
Optical Thermography Infrastructure to Assess Thermal Distribution in Critically Ill ChildrenMonisha Shcherbakova, Rita Noumeir, Michael Levy, et al.Journal of the Neurological Sciences|May 10, 2011
Needle type and the risk of post-lumbar puncture headache in the outpatient neurology clinicEdward R Hammond, Zhuangjun Wang, Nihal Bhulani, et al.Multiple Sclerosis and Related Disorders|November 10, 2023
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosisNegar Molazadeh, Tetsuya Akaishi, Gauruv Bose, et al.Journal of Clinical Medicine|June 16, 2019
Deregulation of miRNA in Helicobacter pylori-Induced Gastric MALT Lymphoma: From Mice to HumanAlice Blosse, Michael Levy, Cyrielle Robe, et al.Journal of Neuroimmunology|September 21, 2021
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorderNegar Molazadeh, Angeliki G Filippatou, Eleni S Vasileiou, et al.Multiple Sclerosis and Related Disorders|August 15, 2023
Is it ethical to use teriflunomide as an active comparator in phase 3 trials?Gavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 10, 2010
n-Dodecyl-β-D-maltoside inhibits aggregation of human interferon-β-1b and reduces its immunogenicityRobert A Rifkin, Edward T Maggio, Sonny Dike, et al.Pageof 52